Skip to main content
Go to the home page of the European Commission (opens in new window)
English en
CORDIS - EU research results
CORDIS

Training network in drug discovery targeting TRIM Ubiquitin ligases in disease

Project description

Research training consortium for drug discovery targeting protein ubiquitination

Protein ubiquitination is a post-translational modification that controls the degradation, signalling and activity of all proteins by targeting them with the peptide ubiquitin. E3 ubiquitin ligases transfer and link the ubiquitin to the target proteins, enabling the specificity of the ubiquitination process. Tripartite motif (TRIM) proteins belong to a family of E3 ubiquitin ligases and are implicated in cancer and neurodegenerative and muscular disorders. Funded by the Marie Skłodowska-Curie Actions programme, the TRIM-NET project is creating an international consortium of partners with expertise in TRIM proteins, providing early stage researchers with essential skills for future research and drug discovery. The project research aims to uncover how TRIM proteins contribute to disease and to develop therapeutic interventions.

Objective

The TRIM-NET innovative training programme will provide Early-Stage Researchers with the skills to identify novel therapeutic targets and develop the strategies to validate them in preclinical studies. Integrating complementary expertise and multidisciplinary approaches TRIM-NET aims to address this goal, focussing on the Tripartite motif (TRIM) family of Ubiquitin E3 ligases, which plays an important role in many physiological processes. The importance of the role of TRIM proteins in these processes is underpinned by their recognised involvement in many disease processes such as cancer, neurodegeneration and rare genetic diseases. As such, they are excellent targets for therapeutic manipulation. The TRIM-NET consortium created a critical mass with complementary and interdisciplinary expertise, from Life Science to Chemistry, around this family of proteins to identify and exploit common targeting strategies for translational applications. The consortium is designed to train a cohort of researchers in skills and expertise essential for biomedical research in the era of personalised medicine, focussing on determining how: i) TRIM proteins contribute to disease; ii) to develop strategies to modulate TRIM proteins activity; iii) to design high throughput screening assays for drug discovery. The training programme comprises 7 highly integrated work packages: 4 scientific and 3 dedicated to training, dissemination and management. The proposal consists of 12 individual research projects that will form the basis of the research training aspects for the ESR recruited to the programme. As the scientific work packages are highly integrated, recruited ESRs will avail of techniques and training opportunities, including secondments, across the work packages. Through a unique international partnership between academic and non-academic partners the TRIM-NET training programme will provide ESRs with skills that are essential for future biomedical research in industry and academia.

Fields of science (EuroSciVoc)

Keywords

Programme(s)

Topic(s)

Funding Scheme

MSCA-ITN - Marie Skłodowska-Curie Innovative Training Networks (ITN)

See all projects funded under this funding scheme

Call for proposal

(opens in new window) H2020-MSCA-ITN-2018

See all projects funded under this call

Coordinator

UNIVERSITA DEGLI STUDI DI TRIESTE
Net EU contribution
€ 522 999,36
Address
PIAZZALE EUROPA 1
34127 Trieste
Italy
Region
Nord-Est Friuli-Venezia Giulia Trieste
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 522 999,36

Participants (8)

Partners (5)